Skip to main content

Advertising Disclaimer »

Main menu

  • Journals
    • Pediatrics
    • Hospital Pediatrics
    • Pediatrics in Review
    • NeoReviews
    • AAP Grand Rounds
    • AAP News
  • AAP Policy
    • Topic/Program Collections
    • Policy
  • Pediatric Collections
    • COVID-19
    • Racism and Its Effect on Pediatric Health
    • More Collections...
  • Multimedia
    • Video Abstracts
    • Pediatrics On Call Podcast
  • Alerts
    • Table of Contents
    • Insights
  • AAP Career Center
  • Subscribe
  • Other Publications
    • American Academy of Pediatrics

User menu

  • Log in

Search

  • Advanced search
American Academy of Pediatrics

AAP Gateway

Advanced Search

AAP Logo

  • Log in
  • Journals
    • Pediatrics
    • Hospital Pediatrics
    • Pediatrics in Review
    • NeoReviews
    • AAP Grand Rounds
    • AAP News
  • AAP Policy
    • Topic/Program Collections
    • Policy
  • Pediatric Collections
    • COVID-19
    • Racism and Its Effect on Pediatric Health
    • More Collections...
  • Multimedia
    • Video Abstracts
    • Pediatrics On Call Podcast
  • Alerts
    • Table of Contents
    • Insights
  • AAP Career Center
  • Subscribe
FDA UPDATE

Neuropsychiatric events linked to asthma medication

Food and Drug Administration Office of Pediatric Therapeutics and Division of Pediatric and Maternal Health
AAP News April 2015, 36 (4) 18; DOI: https://doi.org/10.1542/aapnews.2015364-18a
  • Article
  • Info & Metrics
  • Comments
Loading

Article Information

vol. 36 no. 4 18
DOI 
https://doi.org/10.1542/aapnews.2015364-18a

Published By 
American Academy of Pediatrics
Print ISSN 
1073-0397
Online ISSN 
1556-3332
History 
  • Published online March 30, 2015.

Copyright & Usage 
Copyright © 2015 by the American Academy of Pediatrics

Author Information

Article usage

Article usage: March 2015 to November 2020

AbstractFullPdf
Mar 20155516
Apr 2015242112
May 2015520
Jun 20151231
Jul 20151810
Aug 2015150
Sep 2015161
Oct 2015911
Nov 2015040
Dec 2015020
Feb 2016022
May 2016031
Aug 2016002
Sep 2016013
Oct 2016021
Jan 2017010
Feb 2017010
Mar 20170184
May 2017010
Aug 2017030
Sep 2017010
Oct 2017031
Nov 2017048
Dec 2017032
Jan 2018001
Feb 2018001
Mar 2018021
Apr 2018003
May 2018020
Jun 2018021
Jul 2018007
Sep 2018009
Oct 20180513
Nov 2018007
Dec 2018002
Jan 2019002
Feb 20190411
Mar 2019019
Apr 2019026
May 2019012
Jun 2019043
Jul 2019004
Aug 2019015
Sep 2019002
Oct 2019031
Nov 2019034
Dec 2019030
Jan 2020030
Feb 2020033
Mar 2020062
Apr 2020010
May 2020011
Jun 2020031
Jul 2020021
Sep 2020086
Oct 2020010
Nov 2020010
PreviousNext
Back to top

Advertising Disclaimer »

In this issue

AAP News: 36 (4)
AAP News
Vol. 36, Issue 4
1 Apr 2015
  • Table of Contents
  • Index by author
View this article with LENS
PreviousNext
Email Article

Thank you for your interest in spreading the word on American Academy of Pediatrics.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Neuropsychiatric events linked to asthma medication
(Your Name) has sent you a message from American Academy of Pediatrics
(Your Name) thought you would like to see the American Academy of Pediatrics web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Request Permissions
Article Alerts
Log in
You will be redirected to aap.org to login or to create your account.
Or Sign In to Email Alerts with your Email Address
Citation Tools
Neuropsychiatric events linked to asthma medication
Food and Drug Administration Office of Pediatric Therapeutics, Division of Pediatric and Maternal Health
AAP News Apr 2015, 36 (4) 18; DOI: 10.1542/aapnews.2015364-18a

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Neuropsychiatric events linked to asthma medication
Food and Drug Administration Office of Pediatric Therapeutics, Division of Pediatric and Maternal Health
AAP News Apr 2015, 36 (4) 18; DOI: 10.1542/aapnews.2015364-18a
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Print
Download PDF
  • Table of Contents

Jump to section

  • Article
  • Info & Metrics
  • Comments

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • How to assess risk of sedation for nontherapeutic procedures in pediatric research
  • Agencies work to increase availability of pediatric-friendly drug formulations
  • Family input vital to rare diseases drug development process
Show more FDA UPDATE

Similar Articles

Subjects

  • Allergy/Immunology
    • Asthma
  • AAP NEWS BY DEPARTMENTS
    • FDA Update
  • Terms of Use
  • Privacy Statement
  • FAQ
  • Contact Us
  • 2021 AAP Journals Catalog
  • Pediatrics
  • Pediatrics in Review
  • Hospital Pediatrics
  • NeoReviews
  • AAP Grand Rounds
  • AAP Career Center
  • shopAAP
  • AAP.org
  • AAP News
  • Visit AAP News on Facebook
  • Follow AAP News on Twitter
American Academy of Pediatrics

© 2021 American Academy of Pediatrics